Romain Altwegg
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.Mathilde Osty, Romain Altwegg, Mélanie Serrero
|Mar 06, 2025
Safety of Advanced Combination Treatment With Selective JAK1 Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience.Cécile Cussac, Pauline Rivière, Romain Altwegg
|Mar 05, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study.Nicolas Richard, Aurélien Amiot, Philippe Seksik
|Feb 28, 2023
Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study.Mathurin Fumery, Stéphane Nancey, Jérôme Filippi
|Dec 19, 2022
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study.Mathurin Fumery, Antoine Defrance, Xavier Roblin
|Nov 19, 2022
Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent.Anthony Buisson, Maria Nachury, Thomas Guilmoteau
Pageof 1
Frequent Collaborators
4 joint publications
David Laharie
3 joint publications
Mathurin Fumery
2 joint publications
Guillaume Bouguen
2 joint publications
Xavier Roblin
2 joint publications
Lucine Vuitton
2 joint publications
Laurent Peyrin-Biroulet
1 joint publications
Anthony Buisson
1 joint publications
Aurélien Amiot
1 joint publications
Antoine Meyer
1 joint publications
Mathieu Uzzan
